New research has mapped the cell types that specialize to form reproductive organs in both sexes, identifying key genes and ...
Researchers at Stanford found a way to cure or prevent Type 1 diabetes in mice using a combined blood stem cell and islet cell transplant. The procedure creates a hybrid immune system that stops ...
A Texas A&M committee ruled that the university’s decision to fire a professor after a student was removed from class for objecting to a children’s literature lesson on gender identity was unjustified ...
The professor will no longer be able to teach a class on diversity after she showed students a diagram that included the “Make America Great Again” slogan as an example of white supremacy. By ...
Hyundai is launching a slate of new vehicles, ranging from EVs to plug-in hybrids (PHEVs) and even fuel-cell electric vehicles. First launched in 2018, the Nexo marked a milestone as Hyundai’s first ...
Cowboys defensive end Marshawn Kneeland dead at 24 Tesla Shareholders Approve Elon Musk’s $1 Trillion Pay Package 10 Secrets McDonald’s Employees Aren't Supposed To Tell You Republicans, including ...
Beyond nominating video games for different categories of awards, The Game Awards has also propagated a Future Class in the past. Those recognized as a part of the Future Class cohort were meant to ...
State-owned Saudi Agricultural & Livestock Investment Co. plans to pursue a full ownership stake in the agribusiness unit of Singapore’s Olam Group Ltd., according to people familiar with the matter.
Thousands of Tesla owners have reportedly joined a class action lawsuit against the automaker in Australia over false claims about its ‘Full Self-Driving’ (FSD) package. Tesla is facing mounting legal ...
Oct 10 (Reuters) - Novo Nordisk (NOVOb.CO), opens new tab has decided to discontinue its cell therapy research and development efforts, a spokesperson for the Danish drugmaker told Reuters on Friday.
Ozempic maker Novo Nordisk (NVO) is closing its cell therapy division as part of a major restructuring drive initiated under the company’s new CEO, Mike Doustdar, Bloomberg News reported on Thursday, ...
Novo Nordisk is ending all work in cell therapy, including a Type 1 diabetes program, amid CEO Maziar Mike Doustdar's reorganization. As part of the move, the company is laying off nearly all of the ...